Selected Publications

Prat V, Rozec B, Gauthier C, Lauzier B.
Human heart failure with preserved ejection versus feline cardiomyopathy: what can we learn from both veterinary and human medicine?
Heart Fail Rev 2017;22:783–794.

Ronjat M, Feng W, Dardevet L, Dong Y, Al Khoury S, Chatelain F, Vialla V, Chahboun S, Lesage F, Darbon H, Pessah I, De Waard M.
In cellulo phosphorylation induces pharmacological reprogramming of maurocalcin, a cell penetrating venom peptide.
Proc Natl Acad Sci U S A. 2016 Apr 26;113(17):E2460-8. 

Roul D, Rozec B, André G, Merlet N, Tran Quang T, Lauzier B, Ferron M, Blanloeil Y, Loirand G, Sauzeau V, Gauthier C.
Increased 2-adrenergic vasorelaxation at the early phase of endotoxemic shock in rats.
Vascul. Pharmacol. 2015 Sep;72:181-9.

Romek KM, Nun P, Remaud GS, Silvestre V, Taiwe Sotoing G, Lecerf-Schmidt F, Boumendjel A, De Waard M, Robins RJ.
A retro-biosynthetic approach to the prediction of biosynthetic pathways from position-specific isotope analysis as shown for tramadol. 
Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8296-301.

Lauzier B, Vaillant F, Merlen C, Gélinas R, Bouchard B, Rivard ME, Labarthe F, Dolinsky VW, Dyck JR, Allen BG, Chatham JC, Des Rosiers C.
Metabolic effects of glutamine on the heart: anaplerosis versus the hexosamine biosynthetic pathway.
J. Mol. Cell Cardiol. 2013 Feb;55:92-100.

Rozec B, Erfanian M, Laurent K, Trochu JN, Gauthier C.
Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.
J. Am. Coll. Cardiol. 2009 Apr 28;53(17):1532-8.

Awards

Patents